Cancer Therapy
Cancer Therapy - Related Videos
08:45
Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
0 Views •
Cited by 8 •
2012
Use of Cerenkov Luminescence Imaging (CLI) for monitoring preclinical cancer treatment is described here. This method takes advantage of Cerenkov Radiation (CR) and optical imaging (OI) to visualize radiolabeled probes and thus provides an alternative to PET in preclinical therapeutic monitoring and drug screening.
02:49
Cancer Therapies
0 Views •
2023
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients. However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49
Cancer Therapies
0 Views •
2021
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients. However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
0 Views •
Cited by 7 •
2016
Photodynamic therapy (PDT) is an alternative choice for lung cancer treatment. To increase the therapeutic effect of PDT, lung cancer-targeted nanoparticles combined with chemotherapy were developed. Both in vitro and in vivo anticancer efficacies of PDT with prepared nanoparticles were evaluated.
02:57
Targeted Cancer Therapies
0 Views •
2021
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body. There are several types of targeted therapies against specific...
FAQs
Each treatment modality attacks cancer through a different biological route. Surgery removes a tumor physically, radiation damages tumor-cell DNA, and cytotoxic drugs interfere with cell division. Targeted therapies act on oncogenic signals, whereas immune therapies activate antitumor defenses. These distinctions help clinicians match treatment effects to the disease and clinical objective.
Combining approaches allows care to address cancer through more than one mechanism. A treatment plan may pair local tumor removal or radiation with drug-based, targeted, or immune-based strategies, depending on tumor type, stage, molecular features, patient health, and treatment goals. The selected combination is therefore individualized rather than universally fixed.
Targeted and immune therapies differ in what they directly influence. Targeted treatment blocks oncogenic signals associated with malignant growth, while immune treatment activates the body's antitumor response. Molecular features help determine whether a signaling pathway is relevant, whereas immune-based treatment is selected within the broader clinical context of tumor characteristics and patient health.
Treatment resistance is a central challenge because an initially effective approach may not maintain cancer control. Current research therefore seeks therapies that improve precision and address resistance while also reducing toxicity. This focus links laboratory advances to clinical goals: preserving or extending treatment benefit without adding unnecessary harm to patients.
Clinical selection begins with the disease and the person, not with a single universal regimen. Clinicians consider tumor type, stage, molecular features, overall patient health, and treatment goals when choosing among or combining modalities. These factors determine whether care emphasizes remission, cancer control, survival extension, or relief of cancer-related effects.
Treatment outcomes can be described in several clinically meaningful ways. Cancer therapy may produce remission, maintain control of disease, prolong survival, or relieve the effects of cancer. These outcomes are not interchangeable, so the appropriate measure depends on the treatment goal and the patient's clinical situation.
Research in clinical cancer therapy increasingly focuses on precision, toxicity, resistance, and access. Precision aims to align treatment with tumor and molecular characteristics; reducing toxicity addresses treatment burden; overcoming resistance seeks more durable benefit; and extending effective care broadens the number of patients who can benefit.